查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1555526

生殖器皰疹市場，按類型、管理途徑、最終用戶、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Genital Herpes Market, By Type, By Route of Administration, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 398 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2023年，生殖器皰疹市場規模為9.8767億美元，2024年至2032年複合年成長率為4.89%。

生殖器皰疹市場-市場動態

生殖器皰疹患病率的增加預計將推動市場的成長

生殖器皰疹是全球最受歡迎的性傳染病 (STI) 之一。這種疾病發生率的增加對市場產生了各種影響，影響了對診斷服務的需求和有效治療替代方案的必要性。據世界衛生組織稱，全球約有 37 億 50 歲以下的人 (67%) 感染 1 型單純皰疹病毒 (HSV-1)，該病毒主要引起口腔皰疹。此外，估計全球有 4.91 億 15 至 49 歲的人 (13%) 受到 2 型單純皰疹病毒 (HSV-2) 的影響，這是生殖器皰疹的主要原因。此外，正在進行的單純皰疹病毒疫苗研究為市場成長提供了相當大的機會。然而，高昂的治療成本可能會對市場的擴張構成挑戰。

生殖器皰疹市場 - 主要見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032）每年將以 4.89% 左右的複合年成長率成長

根據給藥途徑細分，預計 Oral 將在 2023 年顯示最大的市場佔有率

根據最終用戶細分，零售藥局是 2023 年的主導類型

按地區分類，北美是 2023 年的主要收入來源

生殖器皰疹市場-細分分析：

全球生殖器皰疹市場根據類型、給藥途徑、最終用戶和地區進行細分。

市場根據類型分為兩個部分：診斷和治療。隨著持續的研究和意識的提高，診斷和治療市場預計將成長，為患者和醫療保健專業人員提供改進的解決方案。

根據給藥途徑，市場分為三個部分：口服、注射和外用。口服藥物因其系統有效性和使用方便而引領市場，而局部治療則提供有針對性的緩解。注射藥物雖然不太流行，但在治療嚴重疾病方面發揮著至關重要的作用。

根據最終用戶，市場分為兩個主要類別：醫院藥房、零售藥房、線上藥房和其他。零售藥局在市場上佔據主導地位。他們在生殖器皰疹領域發揮著重要作用，提供處方和非處方治療、促進患者教育和加強醫療保健服務。

生殖器皰疹市場 - 地理洞察

該市場地域廣泛，涵蓋北美、拉丁美洲、歐洲、亞太地區、中東和非洲。這些領域根據對商業活動做出貢獻的國家進一步分類。北美在市場成長方面處於領先地位，這主要是由於同性戀者對生殖器皰疹治療的需求不斷成長。該地區生殖器皰疹發病率很高，相當一部分人口受到 HSV-1 和 HSV-2 的影響。這種盛行率的升高強調了徹底的診斷和治療選擇的必要性。美國食品藥物管理局 (FDA) 在新療法的批准和監管方面發揮重要作用，確保市場上提供有效和安全的藥物。根據美國國家醫學圖書館的數據，美國每 1,000 名新生兒中就有 1 人被診斷出患有新生兒皰疹感染，如果母親在懷孕期間感染生殖器 HSV 並將其傳染給胎兒，則風險會增加。由於生殖器皰疹的高盛行率和認知，歐洲成為市場成長的第二大地區。

生殖器皰疹市場-競爭格局：

生殖器皰疹市場呈現出競爭激烈的環境，其特點是有許多參與者從事診斷測試和治療方案的開發、生產和分銷。製造商正在優先考慮旨在創建更精確、更快速的診斷測試的投資。此外，他們正在擴大新市場和地區的影響力，以提高產品的可及性。製藥公司、診斷測試製造商和零售藥局都為提供生殖器皰疹治療和診斷做出了重大貢獻。

最新進展：

2023年11月，雅培實驗室的分子人類乳突病毒（HPV）篩檢測試獲得美國食品藥物管理局的批准，從而增強了該公司的癌症篩檢儀器產品組合。 Alinity M 系列診斷檢測的最新成員適用於根據現有指南進行篩檢以及診斷目的，並提供對可能導致癌症的病毒基因型的全面了解。

2024 年 3 月，太陽製藥工業公司 (Sun Pharmaceutical Industries Inc.) 宣布召回 47,520 瓶 40 毫克藥物和 7,488 瓶 80 毫克製劑，理由是不符合現行良好生產規範 (CGMP) 法規。

目錄

第1章：生殖器皰疹市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按類型分類的生殖器皰疹市場片段
    • 依給藥途徑分類的生殖器皰疹市場片段
    • 最終用戶的生殖器皰疹市場片段
    • 按國家/地區分類的生殖器皰疹市場片段
    • 按地區分類的生殖器皰疹市場片段
  • 競爭洞察

第 3 章：生殖器皰疹主要市場趨勢

  • 生殖器皰疹市場促進因素
    • 市場促進因素的影響分析
  • 生殖器皰疹市場限制
    • 市場限制影響分析
  • 生殖器皰疹市場機會
  • 生殖器皰疹市場未來趨勢

第 4 章：生殖器皰疹產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：生殖器皰疹市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：生殖器皰疹市場格局

  • 2023 年生殖器皰疹市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：生殖器皰疹市場 - 按類型

  • 概述
    • 按類型分類的細分市場佔有率分析
    • 診斷
    • 治療
      • 阿昔洛韋
      • 泛昔洛韋
      • 伐昔洛韋
      • 其他

第 8 章：生殖器皰疹市場 - 按給藥途徑

  • 概述
    • 按給藥途徑分類的細分市場佔有率分析
    • 口服
    • 可注射
    • 專題

第 9 章：生殖器皰疹市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 醫院藥房
    • 零售藥局
    • 網路藥局
    • 其他

第 10 章：生殖器皰疹市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美生殖器皰疹主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按類型）
    • 北美市場規模與預測（按管理途徑）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲生殖器皰疹主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按類型）
    • 歐洲市場規模與預測（按管理途徑）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區生殖器皰疹主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按類型）
    • 亞太地區市場規模與預測（依管理途徑）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲生殖器皰疹主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按類型）
    • 拉丁美洲市場規模與預測（按管理途徑）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲生殖器皰疹主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按類型）
    • 中東和非洲市場規模及預測（按管理途徑）
    • 中東和非洲市場規模和預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 生殖器皰疹產業

  • 競爭儀表板
  • 公司簡介
    • Teva Pharmaceutical Industries Ltd.
    • Abbott Laboratories
    • Sun Pharmaceuticals Industries Ltd.
    • Mylan NV
    • Pfizer Inc.
    • GlaxoSmithKline plc
    • Dr. Reddy's Laboratories, ltd.
    • Novartis AG
    • Valeant Pharmaceuticals International Inc. etc.
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV3635

REPORT HIGHLIGHT

Genital Herpes Market size was valued at USD 987.67 Million in 2023, expanding at a CAGR of 4.89% from 2024 to 2032.

Genital herpes is a prevalent sexually transmitted infection (STI) resulting from the herpes simplex virus (HSV). This condition is marked by recurring episodes of painful sores and blisters in the genital and anal regions. The two types of herpes simplex virus responsible for genital herpes are HSV-1 and HSV-2. According to the World Health Organization, approximately 3.7 billion individuals under the age of 50 were infected with HSV-1 in 2016. Additionally, around 491 million people aged 15 to 49 were reported to have an HSV-2 infection in the same year.

Genital Herpes Market- Market Dynamics

The increasing prevalence of genital herpes is projected to drive the growth of the market

Genital herpes ranks among the most prevalent sexually transmitted infections (STIs) across the globe. The increasing incidence of this condition carries various implications for the market, affecting both the demand for diagnostic services and the necessity for effective treatment alternatives. According to the World Health Organization, approximately 3.7 billion individuals under the age of 50 (67%) worldwide are infected with herpes simplex virus type 1 (HSV-1), which primarily causes oral herpes. Additionally, an estimated 491 million people aged 15 to 49 (13%) globally are affected by herpes simplex virus type 2 (HSV-2), the primary cause of genital herpes. Moreover, ongoing investigations into vaccines for the herpes simplex virus offer a considerable opportunity for market growth. Nevertheless, the high cost of treatment may pose a challenge to the expansion of the market.

Genital Herpes Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.89% over the forecast period (2024-2032)

Based on the Route of administration segmentation, Oral was predicted to show maximum market share in the year 2023

Based on End-User segmentation, Retail Pharmacies were the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Genital Herpes Market- Segmentation Analysis:

The Global Genital Herpes Market is segmented based on Type, Route of Administration, End-User, and Region.

The market is classified into two segments according to Type: Diagnosis and Treatment. With ongoing research and heightened awareness, the market for both diagnosis and treatment is anticipated to grow, providing improved solutions for patients and healthcare professionals.

The market is classified into three segments according to the Route of Administration: Oral, Injectable, and Topical. Oral medications lead the market owing to their systemic effectiveness and convenience of use, whereas topical treatments offer targeted relief. Injectable medications, although less prevalent, play a crucial role in managing severe conditions.

The market is segmented into two primary categories according to End-User: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others. Retail Pharmacies hold a dominant position within the market. They play an essential role in the genital herpes sector by providing access to both prescription and over-the-counter treatments, facilitating patient education, and enhancing healthcare delivery.

Genital Herpes Market- Geographical Insights

This market is geographically extensive, encompassing North America, Latin America, Europe, Asia Pacific, the Middle East and Africa. These areas are further categorized based on the countries contributing to business activities. North America leads in market growth, primarily driven by the rising demand for genital herpes treatments among homosexual individuals. The region exhibits a significant prevalence of genital herpes, with a considerable segment of the population affected by HSV-1 and HSV-2. This elevated prevalence underscores the need for thorough diagnostic and treatment options. The U.S. Food and Drug Administration (FDA) is instrumental in the approval and regulation of new therapies, ensuring the availability of effective and safe medications in the marketplace. According to the National Library of Medicine, 1 in 1,000 newborns in the United States is diagnosed with neonatal herpes infection, with the risk increasing if the mother contracts genital HSV infection during pregnancy and transmits it to the fetus. Europe ranks as the second-largest region for market growth, attributed to the high prevalence and awareness of genital herpes.

Genital Herpes Market- Competitive Landscape:

The genital herpes market exhibits a competitive environment, characterized by numerous participants engaged in the development, production, and distribution of diagnostic tests and therapeutic options. Manufacturers are prioritizing investments aimed at creating more precise and rapid diagnostic tests. Additionally, they are broadening their reach into new markets and regions to enhance product accessibility. Pharmaceutical firms, diagnostic test manufacturers, and retail pharmacies each contribute significantly to the provision of treatments and diagnostics for genital herpes.

Recent Developments:

In November 2023, Abbott Laboratories obtained approval from the U.S. Food and Drug Administration for its molecular human papillomavirus (HPV) screening test, thereby enhancing the company's portfolio of cancer screening instruments. This latest addition to the Alinity M series of diagnostic assays is suitable for screening by existing guidelines, as well as for diagnostic purposes, and offers comprehensive insights into the genotypes of the virus that may lead to cancer.

In March 2024, Sun Pharmaceutical Industries Inc. announced the recall of 47,520 bottles of the 40 mg medication and 7,488 bottles of the 80 mg formulation, citing deviations from Current Good Manufacturing Practice (CGMP) regulations.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL GENITAL HERPES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Teva Pharmaceutical Industries Ltd.
  • Abbott Laboratories
  • Sun Pharmaceuticals Industries Ltd.
  • Mylan N.V.
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Dr. Reddy's Laboratories, ltd.
  • Novartis AG
  • Valeant Pharmaceuticals International Inc. etc.
  • Others

GLOBAL GENITAL HERPES MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Diagnosis
  • Treatment
  • Acyclovir
  • Famciclovir
  • Valacyclovir
  • Others

GLOBAL GENITAL HERPES MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

  • Oral
  • Injectable
  • Topical

GLOBAL GENITAL HERPES MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

GLOBAL GENITAL HERPES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Genital Herpes Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Genital Herpes Market Snippet by Type
    • 2.1.2. Genital Herpes Market Snippet by Route of Administration
    • 2.1.3. Genital Herpes Market Snippet by End-User
    • 2.1.4. Genital Herpes Market Snippet by Country
    • 2.1.5. Genital Herpes Market Snippet by Region
  • 2.2. Competitive Insights

3. Genital Herpes Key Market Trends

  • 3.1. Genital Herpes Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Genital Herpes Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Genital Herpes Market Opportunities
  • 3.4. Genital Herpes Market Future Trends

4. Genital Herpes Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Genital Herpes Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Genital Herpes Market Landscape

  • 6.1. Genital Herpes Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Genital Herpes Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. Diagnosis
    • 7.1.3. Treatment
      • 7.1.3.1. Acyclovir
      • 7.1.3.2. Famciclovir
      • 7.1.3.3. Valacyclovir
      • 7.1.3.4. Others

8. Genital Herpes Market - By Route of Administration

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Route of Administration, 2023 & 2032 (%)
    • 8.1.2. Oral
    • 8.1.3. Injectable
    • 8.1.4. Topical

9. Genital Herpes Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 9.1.2. Hospital Pharmacies
    • 9.1.3. Retail Pharmacies
    • 9.1.4. Online Pharmacies
    • 9.1.5. Others

10. Genital Herpes Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Genital Herpes Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Genital Herpes Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Genital Herpes Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Genital Herpes Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Genital Herpes Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Genital Herpes Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Teva Pharmaceutical Industries Ltd.
    • 11.2.2. Abbott Laboratories
    • 11.2.3. Sun Pharmaceuticals Industries Ltd.
    • 11.2.4. Mylan N.V.
    • 11.2.5. Pfizer Inc.
    • 11.2.6. GlaxoSmithKline plc
    • 11.2.7. Dr. Reddy's Laboratories, ltd.
    • 11.2.8. Novartis AG
    • 11.2.9. Valeant Pharmaceuticals International Inc. etc.
    • 11.2.10. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us